chr9-75146721-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_012383.5(OSTF1):c.625G>A(p.Asp209Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000545 in 1,609,892 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D209Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_012383.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OSTF1 | NM_012383.5 | c.625G>A | p.Asp209Asn | missense_variant | 10/10 | ENST00000346234.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OSTF1 | ENST00000346234.7 | c.625G>A | p.Asp209Asn | missense_variant | 10/10 | 1 | NM_012383.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152102Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000278 AC: 69AN: 248596Hom.: 0 AF XY: 0.000260 AC XY: 35AN XY: 134404
GnomAD4 exome AF: 0.000565 AC: 824AN: 1457790Hom.: 1 Cov.: 28 AF XY: 0.000576 AC XY: 418AN XY: 725270
GnomAD4 genome AF: 0.000348 AC: 53AN: 152102Hom.: 0 Cov.: 33 AF XY: 0.000296 AC XY: 22AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2024 | The c.625G>A (p.D209N) alteration is located in exon 10 (coding exon 10) of the OSTF1 gene. This alteration results from a G to A substitution at nucleotide position 625, causing the aspartic acid (D) at amino acid position 209 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at